leuprorelin (CKD-841) / Chong Kun Dang 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   1 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
leuprorelin (CKD-841) / Chong Kun Dang
NCT04840745: The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1

Not yet recruiting
1
32
RoW
CKD-841 A-1 3.75mg, CKD-841, CKD-841 A-1 1.88mg, CKD-841 D 2.92mg, Leuplin Inj. 3.75 mg, Leuplin.Inj
Chong Kun Dang Pharmaceutical, Severance Hospital
Early Puberty
10/21
11/21

Download Options